REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)(RVMDW.US)

longbridge loading
Company Encyclopedia
View More
name
REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)
RVMDW.US
News
View More

Atha Energy secures $25M in LIFE private placement for flow-through shares.

The number of new COVID-19 cases in the country has increased by 15% in the past week, with over 20,000 new infections reported. Hospitalizations have also risen by 10% during the same period, with a total of 5,000 individuals currently receiving treatment. The vaccination rate continues to climb steadily, with over 40% of the population now fully vaccinated. Authorities are urging the public to adhere to safety protocols to prevent further spread of the virus.

Unusual Whales·
Unusual Whales·

16:06 ET Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable

Jurek Kozyra, CEO of Nanovery, discusses on the Disruption Interruption podcast how DNA nanorobots and AI are revolutionizing molecular medicine. These innovations aim to reduce drug development times from 10-15 years to mere hours, potentially curing diseases by targeting mRNA. Kozyra highlights the inefficiencies of traditional medicine and the promise of nanorobots that can detect diseases in blood samples within 2-4 hours, significantly faster than conventional methods. This technology has shown promising results in clinical settings, marking a significant advancement in rapid diagnostics and drug discovery.

prnewswire·
US
CURE
-1.70%
US
NNOX
+1.66%
prnewswire·
US
CURE
-1.70%
US
NNOX
+1.66%

He Yi responded to users' expectations for the CZ role: Diversity needs to be respected, and being down-to-earth does not prevent one from looking up at the stars.

In response to a user's opinion that "CZ should not only focus on creating memes in the cryptocurrency circle, but should devote himself to future technologies such as AI, human regeneration, and Mars exploration," He Yi responded on social media that diversity itself is an important value of the industry and should be fully respected.

CoinLive·
US
AI
-2.73%
CoinLive·
US
AI
-2.73%

House dust mite disease market shows steady growth at 3.5% CAGR (2025-2034) due to rising allergic conditions, with focus on allergen-specific immunotherapies like sublingual tablets.

The market for treating house dust mite disease is steadily growing due to the increasing global presence of allergic rhinitis and asthma associated with indoor allergens. The rise in adoption of allergen-specific immunotherapies, such as sublingual tablets, is broadening treatment choices. This growth is fueled by the increasing number of individuals affected by these conditions.

Unusual Whales·
Unusual Whales·

10 clinical trials to watch in the first half of 2026

The biotechnology industry is starting 2026 with renewed momentum, marked by increased dealmaking and rising market values for successful biotechs. A key stock index for biotech surged by a third last year, reflecting a resurgence of generalist investors. The emergence of a trillion-dollar drugmaker highlights the sector's growth, driven by promising clinical trial results. The first half of 2026 will feature 10 significant clinical trials in areas such as obesity, infectious diseases, and rare disorders, which are anticipated to attract further investment and interest.

biopharmadive·
US
RARE
-2.37%
biopharmadive·
US
RARE
-2.37%
Posts
View More

The recent biotech stock market is really a tale of two extremes. CRSP and NTLA in hand are still struggling, chasing the dream of gene editing but completely missing the big surge of MLTX and ELVN, w...

© 2026 Longbridge｜Disclaimer